One promising strategy for an effective vaccine against HIV-1 focuses on designer antibodies that have much broader potency than most specific antibodies. These broadly neutralizing antibodies (bNAbs) can handle the high mutation rate of HIV particles that makes normal, very specific antibodies useless within a short space of time. A study published by Cell Press on March 28th in the journal iCell/i reveals surprising mutations in these antibodies that are crucial ...
via Medindia Health News
More READ
No comments:
Post a Comment